Skip to main content
. 2014 Jan 31;12(2):886–898. doi: 10.3390/md12020886

Figure 1.

Figure 1

Effects of fucoidan on survival times in mouse model of endotoxemia. Date represents the mean ± S.D. n = 15. group I—mice, injected intraperitoneally with LPS in dose LD100; group II—mice, injected with lipopolysaccharide (LPS) in dose LD100 and then treated with fucoidan in dose 5 mg/kg (medical scheme: 3 times a day subcutaneously); group III—mice, treated with fucoidan (preventive scheme: for 10 days daily subcutaneously) and then injected with LPS in dose LD100; group IV—mice, treated with fucoidan in dose 50 mg/kg per os for 3 weeks daily and then injected with LPS in dose LD100; *—the significance level of differences between III and I; IV and group I(p <0.05) (z ≥ 2021).